Indo US Bio-Tech Limited (INDOUS.BO) has a profit margin of 4.47%, below the sector sector average of 12.13%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
As of the most recent data (September 2026), INDOUS.BO shows a profit margin of 4.47%. That compares with 14.25% in the prior-year period — down 68.6% year over year. That is below the sector sector average of 12.13%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, INDOUS.BO's profit margin is now 4.47% (was 14.25%) — a 68.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Indo US Bio-Tech Limited is outperforming or lagging.
The its sector sector average profit margin is about 12.13%. Indo US Bio-Tech Limited is at 4.47%, which is lower that average. That is roughly 63.1% below the sector mean. Use the comparison chart on this page to see how INDOUS.BO stacks up against individual peers as well.
That compares with 14.25% in the prior-year period — down 68.6% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Indo US Bio-Tech Limited with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Indo US Bio-Tech Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 4.47%) with ownership activity and broader fundamentals.